Pain and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ 07631, USA.
Postgrad Med. 2012 May;124(3):131-8. doi: 10.3810/pgm.2012.05.2556.
Prescription opioid analgesic therapy can be effective in managing chronic noncancer pain in appropriately selected patients. However, the risks and benefits of prescription opioids should be carefully considered when treating this patient population. A dramatic increase in opioid-related morbidity and mortality has been observed in the United States in the past decade. Therefore, health care providers must balance the treatment of chronic pain with the need to minimize the risks of opioid misuse, abuse, addiction, and diversion. Current literature suggests that most patients with chronic pain are managed at the primary care level. However, many of these practitioners are not skilled in risk assessment, stratification, and monitoring. This article reviews strategies and tools that providers may implement to help identify appropriate patients for chronic opioid therapy and recognize signs of drug-related aberrant behaviors and abuse. In addition, the potential role of abuse-deterrent, extended-release opioid formulations to reduce risk in patients and nonmedical users of opioids is introduced. Collectively, these preventative measures may effectively reduce opioid misuse, abuse, and diversion without denying adequate analgesia in appropriate patients.
处方类阿片类镇痛药可有效治疗合适患者的慢性非癌性疼痛。然而,在治疗此类患者人群时,应仔细权衡处方类阿片的风险和益处。过去十年,美国观察到与阿片类药物相关的发病率和死亡率显著增加。因此,医疗保健提供者必须在治疗慢性疼痛的同时,尽量降低阿片类药物滥用、误用、成瘾和转移的风险。目前的文献表明,大多数慢性疼痛患者在初级保健水平得到管理。然而,这些从业者中许多人不擅长风险评估、分层和监测。本文综述了提供者可实施的策略和工具,以帮助识别适合慢性阿片类药物治疗的患者,并识别与药物相关的异常行为和滥用的迹象。此外,还介绍了具有防滥用、延长释放剂型的阿片类药物,以降低患者和非医疗用阿片类药物使用者的风险。总之,这些预防措施可在不影响合适患者获得充分镇痛的情况下,有效减少阿片类药物的滥用、误用和转移。